Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Rheos Medicines identifies new MALT1 inhibitors

May 12, 2022

Sichuan Haisco Pharmaceutical divulges new JAK inhibitors

May 12, 2022

Kumquat Biosciences patents SOS1/KRAS interaction inhibitors

May 12, 2022

Accent Therapeutics discloses METTL3 inhibitors

May 11, 2022

AC Immune synthesizes MAPT aggregation inhibitors

May 11, 2022

Proxygen and collaborators present new compounds for cancer

May 11, 2022

Chinese researchers describe new ADCs for cancer

May 11, 2022

Rheinische Friederich-Wilhelms-Universitaet Bonn discloses MRGPRX4 agonists

May 11, 2022

Shanghai De Novo Pharmatech synthesizes new ATR kinase inhibitors

May 10, 2022

Beijing Jacobio Pharmaceuticals identifies new glutaminase inhibitors

May 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.